Morgan Lewis Ranks Highly Among Life Sciences M&A Firms in 2009

WASHINGTON, D.C., March 8, 2010: In 2009, Morgan Lewis placed highly among global law firms in BioPharm Insight’s annual rankings of the year’s licensing and mergers and acquisitions activity. Some of the firm’s accomplishments include:

• Ranked second, legal adviser to North American licensing agreements based on both value and on volume
• Ranked second, legal adviser to European licensing agreements based on volume
• Ranked third, legal adviser to global licensing agreements based on both value and on volume
• Ranked fourth, legal adviser to European licensing agreements based on value
• Ranked fourth, legal adviser to European mergers and acquisitions based on volume
• Ranked fourteenth, legal adviser to global biotech and pharma mergers and acquisitions based on volume